ARTICLE | Financial News

Innovent raises $260M series D round

November 29, 2016 10:24 PM UTC

Chinese mAb play Innovent Biologics Inc. (Suzhou, China) raised $260 million in a series D round led by new investor Future Industry Investment Fund, a fund managed by a State Development & Investment Corp. affiliate. New investors China Life Private Equity Ltd., Milestone, Ping An Ventures and Taikang Insurance Group also participated, as did existing investors Legend Capital, Temasek Capital and Hillhouse Capital.

According to BioCentury's BCIQ database, the round is the largest private financing for a Chinese biotech and the seventh largest venture equity round for a private biotech worldwide since BioCentury began tracking financings in 1994...

BCIQ Company Profiles

Innovent Biologics Inc.